This Article Full Text Full Text (PDF) All Versions of this Article: 29/3/330    most recent Author Manuscript (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Valtonen-André, C. Articles by Lundwall, A. Search for Related Content PubMed PubMed Citation Articles by Valtonen-André, C. Articles by Lundwall, A.

Beta-Microseminoprotein in Serum Correlates With the Levels in Seminal Plasma of Young, Healthy Males

HANS LILJA^*,

ALEKSANDER GIWERCMAN

From the ^* Department of Laboratory Medicine, Division of Clinical Chemistry, Lund University, Malmö University Hospital, Malmö, Sweden; the Department of Clinical Laboratories, Urology, and Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; and the Department of Clinical Sciences, Fertility Center, Lund University, Malmö University Hospital, Malmö, Sweden.

Correspondence to: Åke Lundwall, Wallenberglaboratory, 4th floor, University Hospital MAS, SE-205 02 Malmö, Sweden (e-mail: ake.lundwall{at}med.lu.se).

Beta-microseminoprotein (MSP) is one of the most abundant proteins secreted by the prostate gland. Because MSP is also synthesized in nonreproductive organs, the establishment of a solid relationship between the levels of MSP in serum and semen is crucial for future studies connecting MSP with aging or diseases of the prostate gland. We developed a specific, competitive, europium-based immunoassay to measure MSP in serum and seminal plasma. We also produced recombinant MSP in insect cells using baculo virus and purified it to homogeneity by a novel approach with ethanol extraction and gel filtration. The median values of MSP in 205 young men were 12 µg/L (2.5–97.5 percentile, 4.9–26 µg/L) in serum and 0.53 g/L (2.5–97.5 percentile, 0.13–2.0 g/L) or 1.8 mg (2.5–97.5 percentile, 0.32–6.6 mg) in seminal plasma. MSP in serum showed significant correlation to MSP in seminal plasma (r = .50, P < .001). Significant correlations were also found in seminal plasma between MSP and prostate-specific antigen (PSA) (r = .65, P < .001) and between MSP and Zn²⁺ (r = .54, P < .001). The yield of recombinant MSP in culture medium was 35 mg/L or higher, and recovery following ethanol extraction was 80%–90%. MSP in serum reflects the prostate secretion of MSP, and correlations were also found in seminal plasma between MSP and PSA and Zn²⁺. This suggests that MSP in serum can be used as a marker of prostate secretion, despite the contribution from extra prostatic tissues.

     Key words: Expression, immunoassay, prostate, purification, semen

This article has been cited by other articles:

				K. M. Waters, D. O. Stram, L. Le Marchand, R. J. Klein, C. Valtonen-Andre, M. T. Peltola, L. N. Kolonel, B. E. Henderson, H. Lilja, and C. A. Haiman A Common Prostate Cancer Risk Variant 5' of Microseminoprotein-{beta} (MSMB) Is a Strong Predictor of Circulating {beta}-Microseminoprotein (MSP) Levels in Multiple Populations Cancer Epidemiol. Biomarkers Prev., October 1, 2010; 19(10): 2639 - 2646. [Abstract] [Full Text] [PDF]

				X. Xu, C. Valtonen-Andre, C. Savblom, C. Hallden, H. Lilja, and R. J. Klein Polymorphisms at the Microseminoprotein-{beta} Locus Associated with Physiologic Variation in {beta}-Microseminoprotein and Prostate-Specific Antigen Levels Cancer Epidemiol. Biomarkers Prev., August 1, 2010; 19(8): 2035 - 2042. [Abstract] [Full Text] [PDF]